CLINICAL EVALUATION OF CHEMOENDOCRINE COMBINATION THERAPY WITH CYCLOPHOSPHAMIDE, MEDROXYPROGESTERONE ACETATE, AND DOXIFLURIDINE (DMpC THERAPY) ON ADVANCED AND RECURRENT BREST CANCER
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.